Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 201

1.

Robert J. Genco, DDS, PhD (1938-2019).

Taubman MA, Giannobile WV.

J Dent Res. 2019 Jun;98(6):609-610. doi: 10.1177/0022034519845901. No abstract available.

PMID:
31107141
2.

Robert J. Genco: Pioneer in Oral Science Advancement.

Taubman MA.

J Dent Res. 2018 Jul;97(7):737-741. doi: 10.1177/0022034518770607. Epub 2018 Jun 1.

PMID:
29856682
3.

OC-STAMP promotes osteoclast fusion for pathogenic bone resorption in periodontitis via up-regulation of permissive fusogen CD9.

Ishii T, Ruiz-Torruella M, Ikeda A, Shindo S, Movila A, Mawardi H, Albassam A, Kayal RA, Al-Dharrab AA, Egashira K, Wisitrasameewong W, Yamamoto K, Mira AI, Sueishi K, Han X, Taubman MA, Miyamoto T, Kawai T.

FASEB J. 2018 Jul;32(7):4016-4030. doi: 10.1096/fj.201701424R. Epub 2018 Mar 13.

4.

B10 Cells Alleviate Periodontal Bone Loss in Experimental Periodontitis.

Wang Y, Yu X, Lin J, Hu Y, Zhao Q, Kawai T, Taubman MA, Han X.

Infect Immun. 2017 Aug 18;85(9). pii: e00335-17. doi: 10.1128/IAI.00335-17. Print 2017 Sep.

5.

DC-STAMP Is an Osteoclast Fusogen Engaged in Periodontal Bone Resorption.

Wisitrasameewong W, Kajiya M, Movila A, Rittling S, Ishii T, Suzuki M, Matsuda S, Mazda Y, Torruella MR, Azuma MM, Egashira K, Freire MO, Sasaki H, Wang CY, Han X, Taubman MA, Kawai T.

J Dent Res. 2017 Jun;96(6):685-693. doi: 10.1177/0022034517690490. Epub 2017 Feb 15.

6.

Phosphoglycerol dihydroceramide, a distinctive ceramide produced by Porphyromonas gingivalis, promotes RANKL-induced osteoclastogenesis by acting on non-muscle myosin II-A (Myh9), an osteoclast cell fusion regulatory factor.

Kanzaki H, Movila A, Kayal R, Napimoga MH, Egashira K, Dewhirst F, Sasaki H, Howait M, Al-Dharrab A, Mira A, Han X, Taubman MA, Nichols FC, Kawai T.

Biochim Biophys Acta Mol Cell Biol Lipids. 2017 May;1862(5):452-462. doi: 10.1016/j.bbalip.2017.01.008. Epub 2017 Jan 31.

7.

Corrigendum to "A novel method of sampling gingival crevicular fluid from a mouse model of periodontitis" [J Immunol Methods 438 (2016) 21-25].

Matsuda S, Movila A, Suzuki M, Kajiya M, Wisitrasameewong W, Kayal R, Hirshfeld J, Al-Dharrab A, Savitri IJ, Mira A, Kurihara H, Taubman MA, Kawai T.

J Immunol Methods. 2017 Feb;441:72. doi: 10.1016/j.jim.2017.01.004. No abstract available.

PMID:
28129826
8.

Porphyromonas gingivalis suppresses adaptive immunity in periodontitis, atherosclerosis, and Alzheimer's disease.

Olsen I, Taubman MA, Singhrao SK.

J Oral Microbiol. 2016 Nov 22;8:33029. doi: 10.3402/jom.v8.33029. eCollection 2016. Review.

9.

Soluble RANKL Cleaved from Activated Lymphocytes by TNF-α-Converting Enzyme Contributes to Osteoclastogenesis in Periodontitis.

Kanzaki H, Makihira S, Suzuki M, Ishii T, Movila A, Hirschfeld J, Mawardi H, Lin X, Han X, Taubman MA, Kawai T.

J Immunol. 2016 Nov 15;197(10):3871-3883. Epub 2016 Oct 7.

10.

Lipopolysaccharides-Induced Suppression of Innate-Like B Cell Apoptosis Is Enhanced by CpG Oligodeoxynucleotide and Requires Toll-Like Receptors 2 and 4.

Yu X, Wang Y, Lin J, Hu Y, Kawai T, Taubman MA, Han X.

PLoS One. 2016 Nov 3;11(11):e0165862. doi: 10.1371/journal.pone.0165862. eCollection 2016.

11.

Local Induction of B Cell Interleukin-10 Competency Alleviates Inflammation and Bone Loss in Ligature-Induced Experimental Periodontitis in Mice.

Yu P, Hu Y, Liu Z, Kawai T, Taubman MA, Li W, Han X.

Infect Immun. 2016 Dec 29;85(1). pii: e00645-16. doi: 10.1128/IAI.00645-16. Print 2017 Jan.

12.

A novel method of sampling gingival crevicular fluid from a mouse model of periodontitis.

Matsuda S, Movila A, Suzuki M, Kajiya M, Wisitrasameewong W, Kayal R, Hirshfeld J, Al-Dharrab A, Savitri IJ, Mira A, Kurihara H, Taubman MA, Kawai T.

J Immunol Methods. 2016 Nov;438:21-25. doi: 10.1016/j.jim.2016.08.008. Epub 2016 Aug 30. Erratum in: J Immunol Methods. 2017 Feb;441:72.

13.

A-Disintegrin and Metalloproteinase (ADAM) 17 Enzymatically Degrades Interferon-gamma.

Kanzaki H, Shinohara F, Suzuki M, Wada S, Miyamoto Y, Yamaguchi Y, Katsumata Y, Makihira S, Kawai T, Taubman MA, Nakamura Y.

Sci Rep. 2016 Aug 30;6:32259. doi: 10.1038/srep32259.

14.

Porphyromonas gingivalis exacerbates ligature-induced, RANKL-dependent alveolar bone resorption via differential regulation of Toll-like receptor 2 (TLR2) and TLR4.

Lin J, Bi L, Yu X, Kawai T, Taubman MA, Shen B, Han X.

Infect Immun. 2014 Oct;82(10):4127-34. doi: 10.1128/IAI.02084-14. Epub 2014 Jul 21.

15.

Recent advances in host defense mechanisms/therapies against oral infectious diseases and consequences for systemic disease.

Gaffen SL, Herzberg MC, Taubman MA, Van Dyke TE.

Adv Dent Res. 2014 May;26(1):30-7. doi: 10.1177/0022034514525778. Review.

16.

Activation of Toll‐like receptor 9 inhibits lipopolysaccharide‐induced receptor activator of nuclear factor kappa‐ B ligand expression in rat B lymphocytes.

Yu X, Lin J, Yu Q, Kawai T, Taubman MA, Han X.

Microbiol Immunol. 2014 Jan;58(1):51-60. doi: 10.1111/1348-0421.12129.

17.

DNA-based adaptive immunity protect host from infection-associated periodontal bone resorption via recognition of Porphyromonas gingivalis virulence component.

Han X, LaRosa KB, Kawai T, Taubman MA.

Vaccine. 2014 Jan 3;32(2):297-303. doi: 10.1016/j.vaccine.2013.09.004. Epub 2013 Sep 16.

18.

Porphyromonas gingivalis infection-associated periodontal bone resorption is dependent on receptor activator of NF-κB ligand.

Han X, Lin X, Yu X, Lin J, Kawai T, LaRosa KB, Taubman MA.

Infect Immun. 2013 May;81(5):1502-9. doi: 10.1128/IAI.00043-13. Epub 2013 Feb 25.

19.

Selective serotonin reuptake inhibitors attenuate the antigen presentation from dendritic cells to effector T lymphocytes.

Branco-de-Almeida LS, Kajiya M, Cardoso CR, Silva MJ, Ohta K, Rosalen PL, Franco GC, Han X, Taubman MA, Kawai T.

FEMS Immunol Med Microbiol. 2011 Aug;62(3):283-94. doi: 10.1111/j.1574-695X.2011.00816.x. Epub 2011 Jun 16.

20.

Aggregatibacter actinomycetemcomitans Omp29 is associated with bacterial entry to gingival epithelial cells by F-actin rearrangement.

Kajiya M, Komatsuzawa H, Papantonakis A, Seki M, Makihira S, Ouhara K, Kusumoto Y, Murakami S, Taubman MA, Kawai T.

PLoS One. 2011 Apr 29;6(4):e18287. doi: 10.1371/journal.pone.0018287.

21.

Inhibition of matrix metalloproteinase-9 activity by doxycycline ameliorates RANK ligand-induced osteoclast differentiation in vitro and in vivo.

Franco GC, Kajiya M, Nakanishi T, Ohta K, Rosalen PL, Groppo FC, Ernst CW, Boyesen JL, Bartlett JD, Stashenko P, Taubman MA, Kawai T.

Exp Cell Res. 2011 Jun 10;317(10):1454-64. doi: 10.1016/j.yexcr.2011.03.014. Epub 2011 Mar 21.

22.

Antibody to receptor activator of NF-κB ligand ameliorates T cell-mediated periodontal bone resorption.

Lin X, Han X, Kawai T, Taubman MA.

Infect Immun. 2011 Feb;79(2):911-7. doi: 10.1128/IAI.00944-10. Epub 2010 Nov 15.

23.

Role of periodontal pathogenic bacteria in RANKL-mediated bone destruction in periodontal disease.

Kajiya M, Giro G, Taubman MA, Han X, Mayer MP, Kawai T.

J Oral Microbiol. 2010 Nov 8;2. doi: 10.3402/jom.v2i0.5532.

24.

Expression of receptor activator of nuclear factor-kappaB ligand by B cells in response to oral bacteria.

Han X, Lin X, Seliger AR, Eastcott J, Kawai T, Taubman MA.

Oral Microbiol Immunol. 2009 Jun;24(3):190-6. doi: 10.1111/j.1399-302X.2008.00494.x.

25.

The influence of mineral trioxide aggregate on adaptive immune responses to endodontic pathogens in mice.

Rezende TM, Vieira LQ, Sobrinho AP, Oliveira RR, Taubman MA, Kawai T.

J Endod. 2008 Sep;34(9):1066-71. doi: 10.1016/j.joen.2008.06.006.

26.

Mutans streptococcal infection induces salivary antibody to virulence proteins and associated functional domains.

Nogueira RD, King WF, Gunda G, Culshaw S, Taubman MA, Mattos-Graner RO, Smith DJ.

Infect Immun. 2008 Aug;76(8):3606-13. doi: 10.1128/IAI.00214-08. Epub 2008 May 12.

27.

Susceptibility of periodontopathogenic and cariogenic bacteria to defensins and potential therapeutic use of defensins in oral diseases.

Komatsuzawa H, Ouhara K, Kawai T, Yamada S, Fujiwara T, Shiba H, Kurihara H, Taubman MA, Sugai M.

Curr Pharm Des. 2007;13(30):3084-95. Review.

PMID:
17979751
28.

Interference with immune-cell-mediated bone resorption in periodontal disease.

Han X, Kawai T, Taubman MA.

Periodontol 2000. 2007;45:76-94. Review. No abstract available.

PMID:
17850450
29.

Periodontal bacterial DNA suppresses the immune response to mutans streptococcal glucosyltransferase.

Taubman MA, Han X, Larosa KB, Socransky SS, Smith DJ.

Infect Immun. 2007 Aug;75(8):4088-96. Epub 2007 May 21.

30.

Cross-reactive adaptive immune response to oral commensal bacteria results in an induction of receptor activator of nuclear factor-kappaB ligand (RANKL)-dependent periodontal bone resorption in a mouse model.

Kawai T, Paster BJ, Komatsuzawa H, Ernst CW, Goncalves RB, Sasaki H, Ouhara K, Stashenko PP, Sugai M, Taubman MA.

Oral Microbiol Immunol. 2007 Jun;22(3):208-15.

PMID:
17488448
31.

The new concept of periodontal disease pathogenesis requires new and novel therapeutic strategies.

Taubman MA, Kawai T, Han X.

J Clin Periodontol. 2007 May;34(5):367-9.

PMID:
17448041
32.

Diminished forkhead box P3/CD25 double-positive T regulatory cells are associated with the increased nuclear factor-kappaB ligand (RANKL+) T cells in bone resorption lesion of periodontal disease.

Ernst CW, Lee JE, Nakanishi T, Karimbux NY, Rezende TM, Stashenko P, Seki M, Taubman MA, Kawai T.

Clin Exp Immunol. 2007 May;148(2):271-80. Epub 2007 Mar 9.

33.

Immunogenic and protective potential of mutans streptococcal glucosyltransferase peptide constructs selected by major histocompatibility complex class II allele binding.

Culshaw S, Larosa K, Tolani H, Han X, Eastcott JW, Smith DJ, Taubman MA.

Infect Immun. 2007 Feb;75(2):915-23. Epub 2006 Nov 6.

34.

Innate immune peptide LL-37 displays distinct expression pattern from beta-defensins in inflamed gingival tissue.

Hosokawa I, Hosokawa Y, Komatsuzawa H, Goncalves RB, Karimbux N, Napimoga MH, Seki M, Ouhara K, Sugai M, Taubman MA, Kawai T.

Clin Exp Immunol. 2006 Nov;146(2):218-25.

35.

B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease.

Kawai T, Matsuyama T, Hosokawa Y, Makihira S, Seki M, Karimbux NY, Goncalves RB, Valverde P, Dibart S, Li YP, Miranda LA, Ernst CW, Izumi Y, Taubman MA.

Am J Pathol. 2006 Sep;169(3):987-98.

37.

The scientific and public-health imperative for a vaccine against dental caries.

Taubman MA, Nash DA.

Nat Rev Immunol. 2006 Jul;6(7):555-63. Epub 2006 May 26. Review.

PMID:
16729013
38.

Effect of adoptive transfer of antigen-specific B cells on periodontal bone resorption.

Harada Y, Han X, Yamashita K, Kawai T, Eastcott JW, Smith DJ, Taubman MA.

J Periodontal Res. 2006 Apr;41(2):101-7.

PMID:
16499712
39.

Bacterial-responsive B lymphocytes induce periodontal bone resorption.

Han X, Kawai T, Eastcott JW, Taubman MA.

J Immunol. 2006 Jan 1;176(1):625-31.

40.

Immune response: the key to bone resorption in periodontal disease.

Taubman MA, Valverde P, Han X, Kawai T.

J Periodontol. 2005 Nov;76(11 Suppl):2033-41. Review.

PMID:
16277573
41.

Immune Response: The Key to Bone Resorption in Periodontal Disease.

Taubman MA, Valverde P, Han X, Kawai T.

J Periodontol. 2005 Nov;76 Suppl 11S:2033-2041. doi: 10.1902/jop.2005.76.11-S.2033.

PMID:
29539039
42.

Potassium channel-blockers as therapeutic agents to interfere with bone resorption of periodontal disease.

Valverde P, Kawai T, Taubman MA.

J Dent Res. 2005 Jun;84(6):488-99. Review.

PMID:
15914584
43.

Immunological and protective effects of diepitopic subunit dental caries vaccines.

Smith DJ, King WF, Rivero J, Taubman MA.

Infect Immun. 2005 May;73(5):2797-804.

45.

Influence of microparticle formulation on immunogenicity of SYI, a synthetic peptide derived from Streptococcus mutans GbpB.

Peacock ZS, Barnes LA, King WF, Trantolo DJ, Wise DL, Taubman MA, Smith DJ.

Oral Microbiol Immunol. 2005 Feb;20(1):60-4.

PMID:
15612949
46.

A Caries Vaccine? The state of the science of immunization against dental caries.

Russell MW, Childers NK, Michalek SM, Smith DJ, Taubman MA.

Caries Res. 2004 May-Jun;38(3):230-5. Review.

47.
48.

Outer membrane protein 100, a versatile virulence factor of Actinobacillus actinomycetemcomitans.

Asakawa R, Komatsuzawa H, Kawai T, Yamada S, Goncalves RB, Izumi S, Fujiwara T, Nakano Y, Suzuki N, Uchida Y, Ouhara K, Shiba H, Taubman MA, Kurihara H, Sugai M.

Mol Microbiol. 2003 Nov;50(4):1125-39.

49.

Remote glucosyltransferase-microparticle vaccine delivery induces protective immunity in the oral cavity.

Smith DJ, Lam A, Barnes LA, King WF, Peacock Z, Wise DL, Trantolo DJ, Taubman MA.

Oral Microbiol Immunol. 2003 Aug;18(4):240-8.

PMID:
12823800
50.

Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes.

Midorikawa K, Ouhara K, Komatsuzawa H, Kawai T, Yamada S, Fujiwara T, Yamazaki K, Sayama K, Taubman MA, Kurihara H, Hashimoto K, Sugai M.

Infect Immun. 2003 Jul;71(7):3730-9.

Supplemental Content

Loading ...
Support Center